Nosheen Umar

Dr. Nosheen Umar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
NUNosheen Umar
Nosheen Umar
DKDominic King
Dominic King
JCJoht Singh Chandan
Joht Singh Chandan
NBNeeraj Bhala
Neeraj Bhala
KNKrish Nirantharakumar
Krish Nirantharakumar
NTNigel Trudgill
Nigel Trudgill

2 April 2024 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
NUNosheen Umar
Nosheen Umar
PHPhil Harvey
Phil Harvey
NANicola J Adderley
Nicola J Adderley
SHShamil Haroon
Shamil Haroon
NTNigel Trudgill
Nigel Trudgill
Background: Patients with inflammatory bowel disease (IBD) presenting to primary care may experience diagnostic delays. We aimed to evaluate this and assess whether time to diagnosis is associated with clinical outcomes. Methods: A retrospective cohort study using English primary care data from January 1, 2010, to December 31, 2019, linked to hospital admission data was undertaken. Patients were followed from the first IBD-related presentation in primary care to IBD diagnosis. Associations of time to diagnosis exceeding a year were assessed using a Robust Poisson regression model. Associations between time to diagnosis and IBD-related emergency hospital admissions and surgery were assessed using Poisson and Cox proportional hazards models, respectively. Results: Of 28 092 IBD patients, 60% had ulcerative colitis (UC) and 40% had Crohn’s disease (CD). The median age was 43 (interquartile range, 30-58) years and 51.9% were female. Median time to diagnosis was 15.6 (interquartile range, 4.3-28.1) months. Factors associated with more than a year to diagnosis included female sex (adjusted risk ratio [aRR], 1.23; 95% CI, 1.21-1.26), older age (aRR, 1.05; 95% CI, 1.01-1.10; comparing >70 years of age with 18-30 years of age), obesity (aRR, 1.03; 95% CI, 1.00-1.06), smoking (aRR, 1.05; 95% CI, 1.02-1.08), CD compared with UC (aRR, 1.13; 95% CI, 1.11-1.16), and a fecal calprotectin over 500 μg/g (aRR, 0.89; 95% CI, 0.82-0.95). The highest quartile of time to diagnosis compared with the lowest was associated with IBD-related emergency admissions (incidence rate ratio, 1.06; 95% CI, 1.01-1.11). Conclusion: Longer times to IBD diagnoses were associated with being female, advanced age, obesity, smoking, and Crohn’s disease. More IBD-related emergency admissions were observed in patients with a prolonged time to diagnosis.

18 March 2025 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
NUNosheen Umar
Nosheen Umar
SWSteven Wambua
Steven Wambua
PHPhilip R Harvey
Philip R Harvey
SCSamuel Cusworth
Samuel Cusworth
KNKrishnarajah Nirantharakumar
Krishnarajah Nirantharakumar
NANicola J Adderley
Nicola J Adderley
Introduction: Patients with inflammatory bowel disease (IBD) may experience delays in their diagnosis. This study aimed to develop and validate a risk prediction tool for IBD. Methods: A retrospective cohort study was conducted using primary care data from 2010 to 2019, including symptomatic patients aged ≥18. UK-based primary care databases linked to hospital records were utilized for model development and validation. Cox proportional hazards models were used to derive risk equations for IBD, ulcerative colitis (UC), and Crohn’s disease (CD) in men and women. Candidate predictors included demographics, comorbidities, symptoms, extraintestinal manifestations, and laboratory results. Model performance was evaluated using measures of fit, discrimination, and calibration at 1, 2, 3, and 5 years after symptom onset. Results: In total, 2 054 530 patients were included in the derivation cohort and 673 320 in the validation cohort. In the derivation cohort, 0.7% were diagnosed with IBD (66.3% UC and 33.7% CD). Predictors in the final IBD model included age, smoking, body mass index, gastrointestinal symptoms, extraintestinal manifestations, comorbidities, family history of IBD, and laboratory investigations. The model demonstrated good discrimination and calibration; C-statistic 0.78 (95% confidence interval [CI], 0.77–0.79) in men and 0.78 (95% CI, 0.77–0.79) in women. In the validation cohort, the model tended to slightly overestimate IBD risk at higher risk thresholds. Conclusions: A risk model using patient demographics, symptoms, and laboratory results accurately predicted IBD, UC, and CD at 1, 2, 3, and 5 years after symptom onset, potentially aiding in prioritizing patients for a referral or fecal calprotectin testing in primary care.

6 February 2025 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
SHSyed Shezal Hussain
Syed Shezal Hussain
NUNosheen Umar
Nosheen Umar
UKUmair Kamran
Umair Kamran
BCBenjamin Coupland
Benjamin Coupland
FVFumi Varyani
Fumi Varyani
NTNigel Trudgill
Nigel Trudgill
Radiologically inserted gastrostomy (RIG) allows long-term enteral nutrition when percutaneous endoscopic gastrostomy (PEG) tube insertion is not feasible either due to technical difficulty or a higher risk of complications. The aims of this study were to examine mortality associated with RIG insertion. Adult patients with RIG insertion from 2007 to 2019 were identified in the Hospital Episode Statistics database. Indications and adverse events were identified using International Statistical Classification of Diseases and Related Health Problems, 10th Revision codes. Provider nutrition support data were available from the Getting It Right First Time in Gastroenterology Report 2021. Multivariable logistic regression analysis examined factors associated with 30-day mortality following a RIG. 15,605 patients were studied (68.0 % male; age 64(Interquartile range (IQR) 56-73)). There was a steady increase in the number of RIGs inserted from 510 per year in 2007 to 1787 per year in 2019. 59.9 % of RIGs were inserted as an outpatient. 63.3 % of RIGs were inserted in head and neck cancer patients. Of the patients who had a RIG insertion, 4.7 % had pneumonia within 7 days and 6.9 % died within 30 days of RIG insertion. Thirty-day mortality fell from 12.2 % in 2007 to 5.8 % in 2019. Higher 30-day mortality rates were observed in patients with Dementia (16.4 %) and in NHS providers without a nutrition support nurse (11.5 %). Factors associated with 30 day mortality included: increasing age (>81 years odds ratio (OR) 13.67 (95 % confidence interval (CI) 4.99-37.48), p < 0.001); increasing NHS provider volume of RIG insertion >12 per year (OR 0.69 (95 % CI (0.55-0.88), p = 0.003); RIG insertion during an emergency admission (OR 2.53 (95 % CI 2.19-2.93), p < 0.001); increasing comorbidity Charlson score >5 (OR 1.38 (95 % CI 1.10-1.75), p = 0.006); NHS provider without a nutrition support nurse (OR 1.38 (95%CI 1.09-1.75), p = 0.007) and other neurological conditions than stroke as indication for RIG (OR 1.55 (95%CI 1.24-1.95), p < 0.001). Despite an increase in RIG insertion over the study period, 30-day mortality has fallen by 52 %. Providers without a nutrition support nurse and providers with a lower volume of RIG insertions were associated with higher mortality.

28 August 2026 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
NUNosheen Umar
Nosheen Umar
BCBen Coupland
Ben Coupland
MMMujeeb Ullah Makki
Mujeeb Ullah Makki
DMDave Mcnulty
Dave Mcnulty
PPPrashant Patel
Prashant Patel
NTNigel Trudgill
Nigel Trudgill

26 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SMShahd Mohamed
Shahd Mohamed
NUNosheen Umar
Nosheen Umar
MSMelisa Sia
Melisa Sia
JSJustin Smyth
Justin Smyth
SUSumedha Udumalagala
Sumedha Udumalagala
NTNigel Trudgill
Nigel Trudgill
Purpose: Root cause analysis carried out to establish the likely causes for pancreatic cancer not being diagnosed on previous imaging. Methods: Records of pancreatic cancer patients between 2016 and 2021 at two NHS providers were examined. Post-Imaging Pancreatic Cancer (PIPC) was defined as pancreatic cancer diagnosed 3–18 months after an index scan that did not report cancer. Index and diagnostic imaging were reviewed by two radiologists independently. An algorithm was developed to categorise PIPC. Results: 46 of 600 patients (7.7%) were classified as having PIPC, with 43 CT and 3 MRI scans undertaken 3–18 months before cancer diagnosis. The median age was 75.9 (IQR 69.6–80.2) years, with 58.7% female. PIPCs were categorised as focal lesion reported on index scan in the same pancreatic segment as diagnostic scan (2.2%); imaging changes associated with pancreatic cancer reported on index scan (17.4%); missed focal lesion or imaging changes associated with pancreatic cancer on index scan (26.1%); no focal lesion or imaging changes associated with pancreatic cancer on index scan (54.3%). Following exclusion of two patients (one declined investigations and one was too unwell), 16 of 46 (35%) PIPC patients could have been diagnosed earlier. Twelve had a missed focal lesion, and four had duct dilatation or a focal lesion reported but were inadequately investigated. Conclusions: Approximately three out of 100 pancreatic cancer patients could have been diagnosed earlier due to a missed lesion or inadequately investigated lesion or duct dilatation on index imaging. There are opportunities for earlier diagnosis of pancreatic cancer on imaging.